GlassScriptPhysician profile
Candice Ocampo
NPI 1356711980
$6,825.08
in general payments reported to CMS, 2019-2025
30 companies · $2,362 in 2025
The $2,362 reported for 2025 was more than what 96% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $314 · 2022: $782 · 2023: $877 · 2024: $2,490 · 2025: $2,362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,645 · Travel and Lodging: $1,821 · Education: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,644.72 |
| Travel and Lodging | $1,820.53 |
| Education | $262.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,418.07 | 2022-2025 | Inspire |
| Harmony Biosciences LLC | $534.91 | 2023-2025 | Wakix |
| Glaxosmithkline, LLC. | $433.08 | 2021-2025 | Nucala, Trelegy Ellipta |
| Axsome Therapeutics, INC. | $349.39 | 2023-2025 | Sunosi |
| Jazz Pharmaceuticals INC. | $338.70 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $211.88 | 2021-2024 | Tezspire, Fasenra |
| Electromed, INC. | $188.49 | 2021-2024 | Smartvest |
| Avadel Cns Pharmaceuticals, LLC | $160.63 | 2024-2025 | Lumryz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.55 | 2021-2022 | |
| Genzyme Corporation | $119.69 | 2021-2023 | |
| Actelion Pharmaceuticals US, INC. | $97.69 | 2021-2024 | Uptravi, Opsumit |
| Mylan Specialty L.P. | $93.56 | 2022-2023 | Yupelri |
| Grifols USA, LLC | $85.70 | 2022-2024 | Prolastin-C Liquid, Xembify |
| Genentech USA, INC. | $85.19 | 2022-2023 | Xolair |
| Ani Pharmaceuticals, INC. | $64.89 | 2024 | Purified Cortrophin Gel |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $61.63 | 2025 | Zepbound |
| Sanofi-Aventis U.S. LLC | $57.99 | 2022 | |
| Novartis Pharmaceuticals Corporation | $52.63 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $51.56 | 2022-2023 | Dupixent |
| Inogen, INC. | $38.95 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| United Therapeutics Corporation | $34.61 | 2022 | |
| Atricure, INC. | $34.16 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Mallinckrodt Hospital Products INC. | $27.64 | 2023 | Acthar |
| Biogen, INC. | $27.01 | 2025 | Skyclarys |
| Covis Pharma Gmbh | $25.53 | 2022 | |
| 3b Medical, INC. | $22.29 | 2025 | Luna |
| Vapotherm INC | $19.37 | 2022 | |
| Nabriva Therapeutics, Plc | $15.77 | 2021 | |
| Philips North America LLC | $14.96 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.56 | 2023 | Airduo Digihaler |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candice Ocampo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.